MDM2 and cancer: The mismatch of the less common enantiomers of amino acids with the biological systems of opposite handedness has been exploited in biological chemistry, for example in protease-stable poly-d-peptides which disrupt the MDM2/p53 interaction important in some cancers [7, 8, 9].